Investigator-initiated study led by Dr. Larry Greenbaum of Emory University to evaluate once-daily oral powder TTI-0102, designed to improve adherenceSan Diego, California--(Newsfile Corp. -) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results